Scilex Holding Co (SCLX) stock

SCLXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as SCLXW

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30

$1.56−0.06 (-3.70%)

Close on Nov 12, 2026Market cap $13.25MP/E –Yield –

Scilex price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Scilex's price to book ratio was 26.7× on Oct 31, 2023.

Period	Period end	Value	Change (pts)
2023	Oct 31, 2023	26.7×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is SCLX.

Revenue growth-28.5% · median 164.3%

Gross margin161.1% · median 89.3%

Operating margin-1136.4% · median -147.4%

Net margin-1469.8% · median -161.8%

Advertisement
300 × 250

See a number that looks wrong?